Rapport Therapeutics, Inc.(RAPP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RAPP Rapport Therapeutics, Inc.

交易中 08-16 11:25:43 EDT

21.02

+0.64

+3.14%

最高22.00	最低19.71	成交量2.83万
今开20.19	昨收20.38	日振幅11.26%
总市值7.69亿	流通市值1.93亿	总股本3,658万
成交额59.95万	换手率0.31%	流通股本920.00万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"RAPP","market":"US","secType":"STK","nameCN":"Rapport Therapeutics, Inc.","latestPrice":21.02,"timestamp":1723821923852,"preClose":20.38,"halted":0,"volume":28284,"delay":0,"floatShares":9200000,"shares":36576457,"eps":-15.820606,"marketStatus":"交易中","marketStatusCode":2,"change":0.64,"latestTime":"08-16 11:25:43 EDT","open":20.19,"high":22,"low":19.705,"amount":599532.4125,"amplitude":0.11261,"askPrice":20.96,"askSize":61,"bidPrice":20.56,"bidSize":50,"shortable":3,"etf":0,"ttmEps":-15.820606,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1723838400000},"adr":0,"listingDate":1717732800000,"adjPreClose":20.38,"postHourTrading":{"tag":"盘后","latestPrice":20.38,"preClose":20.38,"latestTime":"16:00 EDT","volume":435,"amount":8865.3,"timestamp":1723752009571},"volumeRatio":0.934371},"requestUrl":"/m/hq/s/RAPP/tweets","defaultTab":"tweets","newsList":[{"id":"2448015096","title":"Rapport Therapeutics(RAPP.US)获TD Cowen首次覆盖，给予买入评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2448015096","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448015096?lang=zh_cn&edition=full","pubTime":"2024-07-02 22:11","pubTimestamp":1719929508,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4566","TD","BK4007","BK4207","BK4139","BK4585","RAPP","LENZ"],"gpt_icon":0},{"id":"2448610153","title":"Rapport Therapeutics(RAPP.US)获杰富瑞投资银行首次覆盖，给予买入评级, 目标价35.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2448610153","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448610153?lang=zh_cn&edition=full","pubTime":"2024-07-02 20:04","pubTimestamp":1719921869,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["RAPP","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2448136817","title":"Rapport Therapeutics(RAPP.US)获Stifel首次覆盖，给予买入评级, 目标价35.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2448136817","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448136817?lang=zh_cn&edition=full","pubTime":"2024-07-02 17:55","pubTimestamp":1719914107,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LENZ","RAPP","BK4007","BK4139"],"gpt_icon":0},{"id":"2448185996","title":"美国研究综述-Atlassian、Crowdstrike Holdings、CS Disco","url":"https://stock-news.laohu8.com/highlight/detail?id=2448185996","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448185996?lang=zh_cn&edition=full","pubTime":"2024-07-02 15:21","pubTimestamp":1719904888,"startTime":"0","endTime":"0","summary":"    路透7月2日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Atlassian、Crowdstrike Holdings 和 CS Disco。要闻             * Atlassian Corp   ：Piper Sandler将其评级从中性上调至增持             * Crowdstrike Holdings Inc   ：Piper Sandler将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BD6J9T35.USD","LU2106854487.HKD","WBA","BK4560","LU2125909759.SGD","LU1923622291.USD","IE00B894F039.SGD","BK4162","RAPP","LU1559883803.SGD","LAW","LU1548497426.USD","LU2355687059.USD","PCOR","LU2125909916.SGD","LU1861215975.USD","LU0957808578.USD","MMSI","CRWD","FWRG","LU0444971666.USD","LU1923622614.USD","TRGP","LU1974910355.USD","LU1861219969.SGD","LU1815333072.USD","CDNS","WAY","BK4023","LU1852331112.SGD","SGXZ23171101.USD","LU1861214812.USD","LU0719512351.SGD","SG9999004303.SGD","BK4187","LU1720051108.HKD","BK4144","LU0566484027.USD","AFL","IE00B19Z9Z06.USD","BK4588","LU2125909593.SGD","BK4167","EVEX","SNPS","BK4528","TEAM","LU0321505439.SGD","BK4198","LU1861220033.SGD"],"gpt_icon":0},{"id":"2448690624","title":"Rapport Therapeutics Inc：杰富瑞初始覆盖买入评级;目标价35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448690624","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448690624?lang=zh_cn&edition=full","pubTime":"2024-07-02 12:35","pubTimestamp":1719894951,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LENZ","BK4007","BK4139","RAPP"],"gpt_icon":0},{"id":"2443552607","title":"詹姆斯·海利报告于2024年6月10日持有Rapport Therapeutics Inc的5.5%股份——SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=2443552607","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2443552607?lang=zh_cn&edition=full","pubTime":"2024-06-15 04:02","pubTimestamp":1718395321,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["RAPP","BK4139","LENZ"],"gpt_icon":0},{"id":"2441906009","title":"更新版 1-由 J&J 支持的 Rapport Therapeutics 首次上市股价上涨 6%，估值达 6.368 亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441906009","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441906009?lang=zh_cn&edition=full","pubTime":"2024-06-07 23:38","pubTimestamp":1717774719,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 )) (在第2-4段增加了细节和背景)    路透6月7日 - 在强生公司  风险投资部门的支持下，Rapport Therapeutics  的股票周五首次上市就上涨了近6%，这家早期疗法开发商的估值为6.368亿美元。在经历了近两年的枯竭期后，美国首次公开募股市场将于2024年重新复苏，经济有望软着陆。这家总部位于波士顿的公司以每股 18 美元的价格在纳斯达克上市，高于其 17 美元的首次公开募股价格--也就是 16 美元至 18 美元区间的中点。这家生物技术公司周四在首次公开募股（IPO）中筹集了 1.54 亿美元， (link)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0122379950.USD","LU0640476718.USD","LU2602419157.SGD","BK4585","LU0889566641.SGD","LU1732800096.USD","RAPP","JNJ","BK4568","LU0466842654.USD","BK4534","LU1585245621.USD","LU2468319806.SGD","BK4532","IE00B19Z3581.USD","IE00B1BXHZ80.USD","LU1059921491.USD","LU2133065610.SGD","IE00B19Z3B42.SGD","LU0795875086.SGD","LU1066051498.USD","LENZ","LU1280957306.USD","LU1066053197.SGD","LU1430594728.SGD","SG9999002232.USD","IE0002270589.USD","LU1244550494.USD","BK4533","LU0882574055.USD","LU1935042991.SGD","LU0792757196.USD","LU1221951129.SGD","LU1032955483.USD","LU1261432733.SGD","LU1196500208.SGD","BK4581","LU1032466523.USD","SG9999002224.SGD","BK4139","LU1244550577.SGD","BK4588","BK4592","IE00B7SZLL34.SGD","BK4007","LU1221951046.USD","LU1732799900.SGD","LU1023059063.AUD","IE00BSNM7G36.USD","LU1057294990.SGD"],"gpt_icon":0},{"id":"2441087067","title":"由 J&J 支持的 Rapport Therapeutics 首次上市股价上涨近 6","url":"https://stock-news.laohu8.com/highlight/detail?id=2441087067","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441087067?lang=zh_cn&edition=full","pubTime":"2024-06-07 23:15","pubTimestamp":1717773312,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透6月7日 - 在强生公司  风险投资部门的支持下，Rapport Therapeutics公司  的股票在周五首次上市 时上涨了近6%，这家早期疗法开发商的估值为6.368亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","LU1023059063.AUD","LU1032955483.USD","JNJ","BK4581","BK4588","LU0889566641.SGD","LU1267930813.SGD","LU1585245621.USD","RAPP","IE00BSNM7G36.USD","LU0912757837.SGD","SG9999002224.SGD","LU1221951129.SGD","LU1074936037.SGD","LU1506573853.SGD","LU0466842654.USD","LU0122379950.USD","LU1732800096.USD","BK4550","LU1066053197.SGD","LU1935042991.SGD","LU2602419157.SGD","LU0114720955.EUR","LU1244550221.USD","SG9999002232.USD","BK4007","BK4592","LU1057294990.SGD","BK4534","IE00B1BXHZ80.USD","LU1280957306.USD","LU1244550577.SGD","LU2347655156.SGD","LU0795875086.SGD","LU0792757196.USD","IE00B7SZLL34.SGD","BK4504","LU1261432733.SGD","LENZ","LU0795875169.SGD","IE0002270589.USD","BK4532","LU2468319806.SGD","BK4585","LU0882574055.USD","BK4559","LU0234572021.USD","SG9999001440.SGD","LU1221951046.USD"],"gpt_icon":0},{"id":"2441067483","title":"临床阶段生物制药公司Rapport Therapeutics Inc.（RAPP）美国IPO首日开盘上涨超5.88%，报18.","url":"https://stock-news.laohu8.com/highlight/detail?id=2441067483","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441067483?lang=zh_cn&edition=full","pubTime":"2024-06-07 23:07","pubTimestamp":1717772835,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/us-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/us-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["RAPP","BK4139","LENZ"],"gpt_icon":0},{"id":"2441683940","title":"强生支持的Rapport(RAPP.US)IPO定价17美元/股 今晚上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2441683940","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441683940?lang=zh_cn&edition=full","pubTime":"2024-06-07 20:30","pubTimestamp":1717763400,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，美国制药商Rapport Therapeutics(RAPP.US)周四表示，计划以每股17美元的价格发行800万股，发行价为每股16-18美元指导区间的中点。该公司表示，已通过首次公开募股(IPO)融资1.36亿美元，公司估值约为6.014亿美元。Rapport由强生(JNJ.US)的风险投资部门支持，开设了一个新项目，为患有中枢神经系统疾病的患者开发小分子药物。Rapport的股票预计将于 6 月 7 日在纳斯达克全球市场开始交易，股票代码为“RAPP”。高盛、杰富瑞、TD Cowen 和 Stifel 担任此次发行的联席账簿管理人。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1133026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1430594728.SGD","BK4532","LU0882574055.USD","LU0466842654.USD","LU0640476718.USD","LU0889566641.SGD","RAPP","LU1244550494.USD","BK4568","BK4559","LU1196500208.SGD","LU1221951046.USD","SG9999001440.SGD","LU2468319806.SGD","LU1066051498.USD","SG9999002232.USD","IE00B19Z3B42.SGD","LU0792757196.USD","IE0002270589.USD","LU1221951129.SGD","LU1059921491.USD","LU1280957306.USD","LU2347655156.SGD","LU1066053197.SGD","LU1032466523.USD","BK4534","LU1732800096.USD","BK4007","LU1261432733.SGD","IE00B1BXHZ80.USD","SG9999002224.SGD","BK4581","LU0234572021.USD","LU0122379950.USD","LU1057294990.SGD","BK4592","BK4504","LU1023059063.AUD","JNJ","LU2133065610.SGD","IE00BSNM7G36.USD","LU0795875086.SGD","LU1032955483.USD","BK4585","LU2602419157.SGD","BK4533","LU1732799900.SGD","BK4588","BK4550","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"2441774893","title":"强生支持的Rapport Therapeutics在美国IPO筹资1.36亿美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2441774893","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441774893?lang=zh_cn&edition=full","pubTime":"2024-06-07 07:52","pubTimestamp":1717717921,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0795875086.SGD","LU1244550577.SGD","SG9999001440.SGD","IE00B1BXHZ80.USD","BK4550","LU1244550221.USD","LU1267930813.SGD","IE00B19Z3B42.SGD","LU0889566641.SGD","RAPP","BK4592","LU2347655156.SGD","LU1732799900.SGD","BK4585","BK4581","JNJ","LU1066051498.USD","LU1430594728.SGD","LU2133065610.SGD","IE00BSNM7G36.USD","BK4533","LENZ","LU1506573853.SGD","LU1280957306.USD","LU1023059063.AUD","LU0882574055.USD","LU0234572021.USD","LU1074936037.SGD","BK4532","BK4534","BK4568","LU0466842654.USD","LU1935042991.SGD","BK4588","BK4139","LU0114720955.EUR","LU1032466523.USD","BK4007","BK4559","LU1261432733.SGD","LU1059921491.USD","LU1057294990.SGD","LU1732800096.USD","LU1032955483.USD","IE00B7SZLL34.SGD","LU0640476718.USD","LU1244550494.USD","LU0795875169.SGD","LU0912757837.SGD","BK4504"],"gpt_icon":0},{"id":"2441774861","title":"由 J&J 支持的 Rapport Therapeutics 在美国首次公开募股中融资 1.36 亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441774861","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441774861?lang=zh_cn&edition=full","pubTime":"2024-06-07 07:51","pubTimestamp":1717717869,"startTime":"0","endTime":"0","summary":"    路透6月6日 - Rapport Therapeutics 公司周四表示，该公司在美国的首次公开募股已募集到 1.36 亿美元，估值约为 6.014 亿美元。此次首次公开募股表明，美国首次公开募股市场在经历了两年的惨淡经营后已强势回归。据Dealogic的数据显示，今年以来，在美国交易所上市的公司已通过IPO募集  150多亿美元，比去年同期的约91亿美元大幅增长。Rapport 的股票预计将于 6 月 7 日开始在纳斯达克交易，股票代码为 \"RAPP\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU1023059063.AUD","LU1244550221.USD","LU1732799900.SGD","BK4532","LU0889566641.SGD","SG9999002224.SGD","LU0122379950.USD","LU1280957306.USD","LU1066051498.USD","BK4533","LU1074936037.SGD","LU1059921491.USD","LU0795875169.SGD","BK4139","LU0792757196.USD","SG9999001440.SGD","IE0002270589.USD","LU1585245621.USD","LU1066053197.SGD","BK4559","LU1221951046.USD","LU1244550494.USD","LU0114720955.EUR","LU1267930813.SGD","LU1196500208.SGD","BK4534","IE00B19Z3B42.SGD","LENZ","LU1244550577.SGD","IE00B7SZLL34.SGD","LU1261432733.SGD","LU0640476718.USD","LU2468319806.SGD","LU1935042991.SGD","LU0234572021.USD","RAPP","BK4550","IE00B1BXHZ80.USD","LU0466842654.USD","LU2602419157.SGD","LU1221951129.SGD","BK4568","LU0912757837.SGD","JNJ","SG9999002232.USD","LU1506573853.SGD","LU2347655156.SGD","LU1057294990.SGD","LU1732800096.USD"],"gpt_icon":0},{"id":"2441776211","title":"Rapport Therapeutics - 其首次公开招股发行价为每股17.00美元的8百万股普通股。","url":"https://stock-news.laohu8.com/highlight/detail?id=2441776211","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441776211?lang=zh_cn&edition=full","pubTime":"2024-06-07 06:54","pubTimestamp":1717714498,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LENZ","RAPP","BK4139"],"gpt_icon":0},{"id":"2440403458","title":"【专注于CNS疾病的生物科技公司Rapport(RAPP.US)设定IPO条款 拟筹资1.36亿美元】智通财经APP获悉，处于临床试验第二阶段的生物科技公司Rapport Therapeutics，主要开发用于中枢神经系统疾病的创新小分子疗法，该公司于当地时间周一宣布美股IPO条款。","url":"https://stock-news.laohu8.com/highlight/detail?id=2440403458","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440403458?lang=zh_cn&edition=full","pubTime":"2024-06-04 15:48","pubTimestamp":1717487319,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4135","CNS","BK4139","03347","LENZ","BK1576","159837","BK1583","RAPP","BK1141"],"gpt_icon":0},{"id":"2440340346","title":"专注于CNS疾病的生物科技公司Rapport(RAPP.US)设定IPO条款 拟筹资1.36亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440340346","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440340346?lang=zh_cn&edition=full","pubTime":"2024-06-04 15:48","pubTimestamp":1717487319,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，处于临床试验第二阶段的生物科技公司Rapport Therapeutics，主要开发用于中枢神经系统疾病的创新小分子疗法，该公司于当地时间周一宣布美股IPO条款。按照拟议范围的中点计算，Rapport Therapeutics完全稀释后的市值将达到大约6.33亿美元。公开资料显示，Rapport Therapeutics专注于发现和开发用于中枢神经系统疾病患者的变革性的小分子药物。Rapport Therapeutics成立于2022年，计划在美股纳斯达克市场上市，代码拟定为“RAPP”。高盛、杰富瑞、TD Cowen和Stifel是Rapport Therapeutics此次IPO交易的联合簿记行。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1130676.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159837","CNS","RAPP","BK4135"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.rapportrx.com","stockEarnings":[{"period":"1week","weight":0.0981},{"period":"1month","weight":-0.2608},{"period":"3month","weight":0.1988},{"period":"ytd","weight":0.1988}],"compareEarnings":[{"period":"1week","weight":0.0423},{"period":"1month","weight":-0.0209},{"period":"3month","weight":0.0446},{"period":"6month","weight":0.1072},{"period":"1year","weight":0.258},{"period":"ytd","weight":0.1636}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Rapport Therapeutics, Inc.于2022年2月根据特拉华州法律注册成立，名称为Precision Neuroscience NewCo, Inc.，并于2022年10月更名为Rapport Therapeutics, Inc.。该公司是一家临床阶段的生物制药公司，专注于通过发现和开发用于中枢神经系统（“CNS”）疾病患者的转化小分子药物，成为精确神经科学的领导者。","exchange":"NASDAQ","name":"Rapport Therapeutics, Inc.","nameEN":"Rapport Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Rapport Therapeutics, Inc.(RAPP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Rapport Therapeutics, Inc.(RAPP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Rapport Therapeutics, Inc.,RAPP,Rapport Therapeutics, Inc.股票,Rapport Therapeutics, Inc.股票老虎,Rapport Therapeutics, Inc.股票老虎国际,Rapport Therapeutics, Inc.行情,Rapport Therapeutics, Inc.股票行情,Rapport Therapeutics, Inc.股价,Rapport Therapeutics, Inc.股市,Rapport Therapeutics, Inc.股票价格,Rapport Therapeutics, Inc.股票交易,Rapport Therapeutics, Inc.股票购买,Rapport Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Rapport Therapeutics, Inc.(RAPP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Rapport Therapeutics, Inc.(RAPP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}